Subscribe To
Fulcrum Therapeutics to Participate at the Upcoming SVB Securities Global Biopharma Conference
CAMBRIDGE, Mass., Feb. 08, 2023 (GLOBE NEWSWIRE) — Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives of patients with genetically defined rare diseases, today announced that management will participate in a virtual presentation at the SVB Securities Global Biopharma Conference on Wednesday, February 15, 2023 at 10:00 AM ET. […] The post Fulcrum Therapeutics to Participate at the Upcoming SVB Securities Global Biopharma Conferenc...
Read More
Content Topics
Fulcrum
Therapeutics
Participate
Upcoming
Securities
Global
Biopharma
Conference
Forex
Posted: Feb 8 2023, 22:00
Author Name: forextv
Views: 102883